Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Thank you, everyone. My name is Gena Wang. I am mid-cap biotech analyst at the Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and the corporate access team who made this virtual health care conference possible.
With that, I would like to introduce our next speakers from Alnylam, Jeff Poulton, Chief Financial Officer; and also Josh Brodsky, also the leader of the IR team.
I will hand over to you, Josh, maybe for the introduction remarks. I just wanted to remind investors, you have to physically click the slide in order to view the slides, and I'm pretty sure Alnylam team will remind everyone on the page they are on.
Okay. With that, I'll hand over to you, Josh.
Terrific. Thanks so much, Gena, and good afternoon, everyone. Again, my name is Josh Brodsky. I'm Director of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |